“This is the first successful vaccination to target pain in osteoarthritis, one of the biggest healthcare challenges of our generation,” she said.
The vaccine stimulates the body’s immune system to release antibodies that fight against NGF. It was first tested on mice with hindrances in their hind legs, a sign of osteoarthritis. The vaccine seemed to cure their physical ailments. The mice were no longer in visible pain and began distributing their weight evenly across all of their legs.
When doctors monitored the antibody levels in the rodents, researchers noted a marked increase.
The breakthrough could affect a huge portion of the world’s population, especially senior citizens. Out of people surveyed in the U.K., a whopping 25 percent of those who suffer from osteoarthritis reported they weren’t provided with adequate treatment for their condition.